|
Feb 24
|
Deciphering Charles River (CRL) International Revenue Trends
|
|
Feb 24
|
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
|
|
Feb 21
|
Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 20
|
Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...
|
|
Feb 20
|
Q4 2024 Charles River Laboratories International Inc Earnings Call
|
|
Feb 19
|
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
|
|
Feb 19
|
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
|
|
Feb 19
|
Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics
|
|
Feb 19
|
Charles River beats quarterly estimates on stable demand for drug development services
|
|
Feb 19
|
Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates
|
|
Feb 19
|
Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4
|
|
Feb 19
|
Charles River: Q4 Earnings Snapshot
|
|
Feb 19
|
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
|
|
Feb 18
|
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
|
|
Feb 17
|
Gear Up for Charles River (CRL) Q4 Earnings: Wall Street Estimates for Key Metrics
|
|
Feb 14
|
Is Now the Right Time to Hold on to Charles River Stock?
|
|
Feb 13
|
Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment
|
|
Feb 12
|
Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Feb 11
|
Charles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with Deciphex
|
|
Feb 11
|
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
|